Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years

Document first published:
Page updated:
Topic:
,
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® 10 micrograms/dose COVID-19 mRNA vaccine to children aged 5 to 11 years in accordance with the national COVID-19 vaccination programme.

This PGD is for the administration of Comirnaty® 10 micrograms/dose COVID-19 mRNA vaccine by registered healthcare practitioners identified in Section 3 of this PGD.

 

Document

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (PDF version)

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (PDF version)

  • PDF
  • 447 KB
  • 24 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

Updated 6 September 2022.

Document

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (Word version)

Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years (Word version)

  • Microsoft Word
  • 252 KB
  • 24 pages

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

Updated 6 September 2022.